$IPAR
INTERPARFUMS INC Stock $ipar

$ipar Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000175392624000405 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$324.0M	$328.7M	$1.318B
YoY Change	3.93%	5.78%	21.26%
Cost Of Revenue	$121.6M	$142.6M	$478.6M
YoY Change	11.78%	4.64%	22.02%
Gross Profit	$202.4M	$186.1M	$839.1M
YoY Change	-0.28%	6.66%	20.83%
Gross Profit Margin	62.47%	56.61%	63.68%
Selling, General & Admin	$134.4M	$167.2M	$587.7M
YoY Change	19.29%	16.52%	19.36%
% of Gross Profit	66.41%	89.86%	70.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.018M	$4.550M	$17.33M
YoY Change	46.25%	18.06%	-23.11%
% of Gross Profit	2.97%	2.44%	2.07%
Operating Expenses	$134.4M	$167.2M	$587.7M
YoY Change	19.29%	16.52%	19.36%
Operating Profit	$67.97M	$18.88M	$251.4M
YoY Change	-24.71%	-39.02%	29.38%
Interest Expense	$1.807M	-$4.153M	$11.25M
YoY Change	-23.33%	104.48%	212.67%
% of Operating Profit	2.66%	-22.0%	4.48%
Other Income/Expense, Net	$2.080M	$192.0K	-$1.789M
YoY Change	-9.84%	-229.73%	2055.42%
Pretax Income	$70.05M	$14.92M	$78.96M
YoY Change	-24.34%	-29.07%	57.14%
Income Tax	$16.75M	$6.689M	$61.82M
% Of Pretax Income	23.91%	44.84%	78.29%
Net Earnings	$41.05M	$10.42M	$152.7M
YoY Change	-24.08%	-37.23%	26.23%
Net Earnings / Revenue	12.67%	3.17%	11.58%
Basic Earnings Per Share	$1.28		$4.77
Diluted Earnings Per Share	$1.27	$0.32	$4.75
COMMON SHARES
Basic Shares Outstanding	32.02M shares	31.98M shares	31.99M shares
Diluted Shares Outstanding	32.27K shares		32.14M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.05M	$182.8M	$182.8M
YoY Change	-59.18%	-28.48%	-28.48%
Cash & Equivalents	$20.98M	$88.46M	$88.46M
Short-Term Investments	$76.08M	$94.30M	$94.30M
Other Short-Term Assets	$34.26M	$29.46M	$29.46M
YoY Change	68.38%	88.23%	88.23%
Inventory	$400.2M	$371.9M	$371.9M
Prepaid Expenses
Receivables	$293.1M	$247.2M	$247.2M
Other Receivables	$5.581M	$7.012M	$7.703M
Total Short-Term Assets	$832.7M	$839.0M	$839.0M
YoY Change	-2.22%	6.51%	6.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.2M	$169.2M	$197.8M
YoY Change	-2.88%	1.5%	1.62%
Goodwill
YoY Change
Intangibles	$288.1M	$296.4M
YoY Change	-2.1%	1.89%
Long-Term Investments
YoY Change
Other Assets	$21.52M	$21.57M	$36.11M
YoY Change	-16.67%	-10.58%	2.36%
Total Long-Term Assets	$516.5M	$530.3M	$530.3M
YoY Change	-2.29%	1.82%	1.82%
TOTAL ASSETS
Total Short-Term Assets	$832.7M	$839.0M	$839.0M
Total Long-Term Assets	$516.5M	$530.3M	$530.3M
Total Assets	$1.349B	$1.369B	$1.369B
YoY Change	-2.25%	4.65%	4.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$106.2M	$97.41M	$97.41M
YoY Change	14.15%	10.21%	10.21%
Accrued Expenses	$135.7M	$178.9M	$184.8M
YoY Change	-28.71%	-16.26%	-15.57%
Deferred Revenue
YoY Change
Short-Term Debt	$8.324M	$4.420M	$4.420M
YoY Change	-53.76%
Long-Term Debt Due	$29.03M	$29.59M	$29.59M
YoY Change	-0.22%	3.64%	3.64%
Total Short-Term Liabilities	$302.5M	$324.7M	$324.7M
YoY Change	-16.49%	-5.75%	-5.75%
LONG-TERM LIABILITIES
Long-Term Debt	$115.9M	$127.9M	$127.9M
YoY Change	-20.12%	-15.58%	-15.58%
Other Long-Term Liabilities	$22.91M	$24.52M	$24.52M
YoY Change	-1.7%	0.75%	0.75%
Total Long-Term Liabilities	$115.9M	$127.9M	$152.4M
YoY Change	-20.12%	-15.58%	-13.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$302.5M	$324.7M	$324.7M
Total Long-Term Liabilities	$115.9M	$127.9M	$152.4M
Total Liabilities	$418.4M	$452.6M	$669.9M
YoY Change	-17.53%	-8.75%	-3.15%
SHAREHOLDERS EQUITY
Retained Earnings	$711.0M	$693.8M
YoY Change	8.65%	11.89%
Common Stock	$32.00K	$32.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$52.86M	$52.86M
YoY Change	22.78%	41.06%
Treasury Stock Shares
Shareholders Equity	$708.1M	$699.4M	$699.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.349B	$1.369B	$1.369B
YoY Change	-2.25%	4.65%	4.65%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$41.05M	$10.42M	$152.7M
YoY Change	-24.08%	-37.23%	26.23%
Depreciation, Depletion And Amortization	$6.018M	$4.550M	$17.33M
YoY Change	46.25%	18.06%	-23.11%
Cash From Operating Activities	-$51.96M	$81.50M	$105.8M
YoY Change	606.17%	-33.92%	-8.14%
INVESTING ACTIVITIES
Capital Expenditures	$1.059M	$46.73M	$6.465M
YoY Change	-56.15%	-51.45%	-80.85%
Acquisitions
YoY Change
Other Investing Activities	$15.29M	$13.49M	$60.63M
YoY Change	-76.19%	-613.67%	-42797.18%
Cash From Investing Activities	$13.92M	-$33.24M	$7.262M
YoY Change	-77.42%	-66.38%	-105.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$9.425M		$28.80M
YoY Change	0.3%		45.01%
Cash From Financing Activities	-$28.13M	-42.74M	-$133.2M
YoY Change	124.06%	-221.89%	192.34%
NET CHANGE
Cash From Operating Activities	-$51.96M	81.50M	$105.8M
Cash From Investing Activities	$13.92M	-33.24M	$7.262M
Cash From Financing Activities	-$28.13M	-42.74M	-$133.2M
Net Change In Cash	-$67.49M	5.511M	-$16.25M
YoY Change	-252.19%	-90.74%	-74.48%
FREE CASH FLOW
Cash From Operating Activities	-$51.96M	$81.50M	$105.8M
Capital Expenditures	$1.059M	$46.73M	$6.465M
Free Cash Flow	-$53.02M	$34.77M	$99.31M
YoY Change	442.5%	28.4%	22.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000822663
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	us-gaap	Loans Payable To Bank LoansPayableToBank		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold		usd
CY2021	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent		usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity		usd
CY2021	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity		usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	259900000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3064000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	139000000
CY2023Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P10Y
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	120000000
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000000
CY2022Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P4Y
CY2021Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P10Y
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P14Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2022	us-gaap	Royalty Expense RoyaltyExpense	87000000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y10M6D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y8M2D
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Requisite Service Period1 DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1	P3Y
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-16469
CY2023	dei	Entity Registrant Name EntityRegistrantName	Inter Parfums, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3275609
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	551 Fifth Avenue
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10176
CY2023	dei	Trading Symbol TradingSymbol	IPAR
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	983.2640
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $.001 par value per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2437984859	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32021700	shares
CY2023	dei	Auditor Firm AuditorFirmId	339
CY2023	dei	Auditor Name AuditorName	Mazars USA LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	88462000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	104713000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	94304000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	150833000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	247240000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	197584000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	371859000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	289984000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7012000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	28803000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	29458000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	15650000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	691000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-56056000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	157000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	839026000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	787724000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169222000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166722000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28613000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27964000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	296356000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	290853000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14545000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11159000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21567000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24120000	usd
CY2023Q4	us-gaap	Assets Assets	1369329000	usd
CY2022Q4	us-gaap	Assets Assets	1308542000	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	4420000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	29587000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	28547000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5951000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5296000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	97409000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	88388000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	178880000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	213621000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8498000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8715000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	324745000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	344567000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	127897000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	151494000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24517000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24335000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32004660	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31967300	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	98565000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90186000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	693848000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	620095000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-40188000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9981665	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9864805	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	52864000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	37475000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	699393000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	616782000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	192777000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	171364000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892170000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	788146000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1369329000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1308542000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1317675000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1086653000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	879516000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	478597000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	392231000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	322614000	usd
CY2023	us-gaap	Gross Profit GrossProfit	839078000	usd
CY2022	us-gaap	Gross Profit GrossProfit	694422000	usd
CY2021	us-gaap	Gross Profit GrossProfit	556902000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	587696000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	492370000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	406459000	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	7749000	usd
CY2021	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	2393000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	251382000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	194303000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	148050000	usd
CY2023	us-gaap	Interest Expense InterestExpense	11253000	usd
CY2022	us-gaap	Interest Expense InterestExpense	3599000	usd
CY2021	us-gaap	Interest Expense InterestExpense	2825000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1582000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1921000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2338000	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	10729000	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5486000	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3403000	usd
CY2023	us-gaap	Other Income OtherIncome	317000	usd
CY2022	us-gaap	Other Income OtherIncome	-50000	usd
CY2021	us-gaap	Other Income OtherIncome	53000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1789000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-84000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2969000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	249593000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	194219000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	151019000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61817000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43182000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40992000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	187776000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	151037000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110027000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	35122000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	30099000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22616000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	152654000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	120938000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	87411000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.77
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.76
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.75
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.78
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.75
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31994328	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31859417	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31676796	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32139702	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31988753	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31835408	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.50
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.00
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2023	us-gaap	Profit Loss ProfitLoss	187776000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	151037000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110027000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax	-3329000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax	2356000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax	-1367000	usd
CY2023	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-1709000	usd
CY2022	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-992000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24042000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-29683000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-42967000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	22422000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-26335000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-44334000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	210198000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	124702000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	65693000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	35122000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	30099000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22616000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	25000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	647000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-375000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6529000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	9358000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	11524000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	41676000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	21388000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	10717000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	168522000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	103314000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	54976000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	788146000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	738332000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	702450000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	187776000	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	281741000	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	896000	usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	10644000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6465000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33756000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	141274000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	46903000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	56746000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1545000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	151037000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110027000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892170000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	788146000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	738332000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	187776000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	151037000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110027000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17331000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22539000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12698000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1734000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2353000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	853000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2525000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3143000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2853000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	317000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-49000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	53000	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	5448000	usd
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	4980000	usd
CY2021	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	7302000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2987000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3604000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-465000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	301000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-227000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-65000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36843000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	59640000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	45395000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	73700000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	98297000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	49815000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-11868000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	13651000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16725000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5290000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4795000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-7503000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3064000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	64738000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	103046000	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-1066000	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	3952000	usd
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2698000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	105774000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	73031000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	119586000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	221111000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1038000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	55691000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7262000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90644000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-187866000	usd
CY2023	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	4325000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	52492000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	157382000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28800000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	19861000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	43056000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8025000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6003000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5393000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1027000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4403000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	80047000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	63743000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	31690000	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	20301000	usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	16056000	usd
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	9836000	usd
CY2023	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	15389000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-133214000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-45568000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78193000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3927000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-493000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11207000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16251000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63674000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1294000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104713000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	168387000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	169681000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88462000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104713000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	168387000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5823000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2987000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2468000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	60990000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	38492000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	40497000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4700000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zxkDgvIHxPn" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z8Le4gYiMKWf">Management Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the consolidated financial statements.</span></p>
CY2023	us-gaap	Revenue Recognition Sales Returns RevenueRecognitionSalesReturns	<p id="xdx_84A_eus-gaap--RevenueRecognitionSalesReturns_zfT9FpRPGDGg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zCRJKZrlWho4">Sales Returns</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company does not permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund liability associated with estimated returns was $<span id="xdx_904_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20231231_zSWNbKVI0mEj" title="Contract with customer, refund liability">5.5 million</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zPG7Iev9Qya6" title="Contract with customer, refund liability">8.6 million</span> at December 31, 2023 and 2022, respectively, and the amounts recognized for the rights to recover products was $<span id="xdx_908_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20231231_zouID8UHwvv2" title="Contract with customer, right to recover products">2.4 million</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zuIXFlBLrfh3" title="Contract with customer, right to recover products">3.2 million</span> at December 31, 2023 and 2022, respectively. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</span></p>
CY2023Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	5500000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	8600000	usd
CY2023Q4	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	2400000	usd
CY2022Q4	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	3200000	usd
CY2023	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p id="xdx_847_eus-gaap--RevenueRecognitionAllowances_zTDhNmDICT71" style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_zaMA8FrRS0G6">Payments to Customers</span></span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records revenues generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.</span></p>
CY2022	us-gaap	Advertising Expense AdvertisingExpense	212400000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	171100000	usd
CY2023	us-gaap	Marketing Expense MarketingExpense	52300000	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	43100000	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	36900000	usd
CY2023	us-gaap	Reclassifications Reclassifications	<p id="xdx_847_eus-gaap--Reclassifications_zZNxjm5dk7J5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zVOcfbnIDHe4">Reclassifications</span></span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="-sec-ix-redline: true">Certain prior year amounts in the accompanying notes to consolidated financial statements have been reclassified to conform with current period presentation.</span></p> <p style="margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="-sec-ix-redline: true"><b><i>Correction of Immaterial Misstatements in Prior Period Financial Statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">During the year ended December 31, 2023, the Company identified an error that caused an overstatement of line items on the previously reported consolidated statement of cash flows. The error does not impact any other consolidated financial statement included herein. Specifically, the error related to the timing of payments to Lacoste in accordance with the acquisition agreement of the Lacoste trademark in 2022</span> which required a payment in 2022 and an additional payment in 2023<span style="font-family: Times New Roman, Times, Serif">. </span>In the 2022 consolidated statement of cash flow, the payment was reported to have been made in full during 2022. <span style="font-family: Times New Roman, Times, Serif">This error had no impact on net income or earnings per share for the year ended December 31, 2022. The impact of the error resulted in a movement of $<span id="xdx_902_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_dxL_c20230101__20231231_zZIx0wDIdrZe" title="Change in Accounts payable and accrued expenses::XDX::3064000"><span style="-sec-ix-hidden: xdx2ixbrl0838">42.1</span></span> million </span><span style="font-family: Times New Roman, Times, Serif">between “Change in Accounts payable and accrued expenses” within operating cash flows and “Payment for intangible assets acquired” within investing cash flows.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="-sec-ix-redline: true">In accordance with Staff Accounting Bulletin (“SAB”) No. 99, Materiality, and SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, the Company evaluated the errors and determined that the impact was not material to any of our previously issued financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_899_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_z4ZLPYfldrYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_z4E8TBomv8Y7">The following table presents a summary of the impact by financial statement line item of the corrections for the year ended December 31, 2022: </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="-sec-ix-redline: true"><b> </b></span></td><td><span style="-sec-ix-redline: true"><b> </b></span></td> <td colspan="10" style="text-align: center"><span style="-sec-ix-redline: true"><b>For the Year Ended December 31, 2022</b></span></td><td><span style="-sec-ix-redline: true"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="-sec-ix-redline: true"><b>Consolidated Statement of Cash Flow</b></span></td><td style="padding-bottom: 1pt"><span style="-sec-ix-redline: true"><b> </b></span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><span style="-sec-ix-redline: true"><b>As previously reported</b></span></td><td style="padding-bottom: 1pt"><span style="-sec-ix-redline: true"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="-sec-ix-redline: true"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="-sec-ix-redline: true"><b>Adjustment</b></span></td><td style="padding-bottom: 1pt"><span style="-sec-ix-redline: true"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="-sec-ix-redline: true"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="-sec-ix-redline: true"><b>As revised</b></span></td><td style="padding-bottom: 1pt"><span style="-sec-ix-redline: true"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="-sec-ix-redline: true">(in thousands)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="-sec-ix-redline: true">Change in Accounts payable and accrued expenses</span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zeNWUxjN6bQb" style="width: 12%; text-align: right" title="Change in accounts payable and accrued expenses"><span style="-sec-ix-redline: true">106,857</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zLD14WOmKMie" style="width: 12%; text-align: right" title="Change in accounts payable and accrued expenses"><span style="-sec-ix-redline: true">(42,119</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_pn3n3_c20220101__20221231__srt--RestatementAxis__custom--RestatementAsRevisedMember_zy3YbMvZlgIi" style="width: 12%; text-align: right" title="Change in accounts payable and accrued expenses"><span style="-sec-ix-redline: true">64,738</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Net cash provided by operating activities</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zV1yt0O54cYa" style="text-align: right" title="Net cash provided by operating activities"><span style="-sec-ix-redline: true">115,150</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwnaw8JyaPWi" style="text-align: right" title="Net cash provided by operating activities"><span style="-sec-ix-redline: true">(42,119</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_c20220101__20221231__srt--RestatementAxis__custom--RestatementAsRevisedMember_zvxX9j27W0df" style="text-align: right" title="Net cash provided by operating activities"><span style="-sec-ix-redline: true">73,031</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Payments for intangible assets acquired</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireIntangibleAssets_iN_pn3n3_di_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zx6cHRViVIxh" style="text-align: right" title="Payments for intangible assets acquired"><span style="-sec-ix-redline: true">(98,865</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireIntangibleAssets_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPlannQBNqdk" style="text-align: right" title="Payments for intangible assets acquired"><span style="-sec-ix-redline: true">42,119</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--PaymentsToAcquireIntangibleAssets_iN_pn3n3_di_c20220101__20221231__srt--RestatementAxis__custom--RestatementAsRevisedMember_z3ayHasv9Rn7" style="text-align: right" title="Payments for intangible assets acquired"><span style="-sec-ix-redline: true">(56,746</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Net cash used in investing activities</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--NetCashProvidedByUsedInInvestingActivities_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxvwrL5ZRqsl" style="text-align: right" title="Net cash used in investing activities"><span style="-sec-ix-redline: true">(132,763</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--NetCashProvidedByUsedInInvestingActivities_pn3n3_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlK5boVhCoLg" style="text-align: right" title="Net cash used in investing activities"><span style="-sec-ix-redline: true">42,119</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98F_eus-gaap--NetCashProvidedByUsedInInvestingActivities_pn3n3_c20220101__20221231__srt--RestatementAxis__custom--RestatementAsRevisedMember_ztlpNKjcGKo1" style="text-align: right" title="Net cash used in investing activities"><span style="-sec-ix-redline: true">(90,644</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> </table> <p id="xdx_853_zrba5GdTmFDi" style="margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p id="xdx_85B_zbKn1BytLGU2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	154000000	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	3100000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	132600000	usd
CY2023	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	one-month Euribor plus 0.75%
CY2023Q4	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.02	pure
CY2023Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.011	pure
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	158733000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	146772000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	213126000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	143212000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	371859000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	289984000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	21500000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	11400000	usd
CY2022Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	55300000	usd
CY2022Q4	us-gaap	Derivative Swaption Interest Rate DerivativeSwaptionInterestRate	0.02	pure
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	132600000	usd
CY2021Q2	us-gaap	Derivative Swaption Interest Rate DerivativeSwaptionInterestRate	0.011	pure
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	221805000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	210119000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	52583000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43397000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169222000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166722000	usd
CY2023	us-gaap	Depreciation Depreciation	9800000	usd
CY2022	us-gaap	Depreciation Depreciation	7500000	usd
CY2021	us-gaap	Depreciation Depreciation	4400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	386343000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	89987000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	296356000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	369373000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	78520000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	290853000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7500000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6800000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	11400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	11400000	usd
CY2023Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	77000000	usd
CY2023Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	64815000	usd
CY2022Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	42338000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23546000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	21128000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	27477000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	26532000	usd
CY2023Q4	ipar	Due Vendors Not Yet Invoiced DueVendorsNotYetInvoiced	41859000	usd
CY2022Q4	ipar	Due Vendors Not Yet Invoiced DueVendorsNotYetInvoiced	105869000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent	10444000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent	8001000	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	5507000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	8604000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5232000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1149000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	178880000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	213621000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	4400000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	0	usd
CY2023Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.045	pure
CY2022Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0	pure
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	157484000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	180041000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	29587000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	28547000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	127897000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	151494000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	29600000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	29800000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	28600000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	15900000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	15900000	usd
CY2023	us-gaap	Long Term Debt Description LongTermDebtDescription	$37.7 million thereafter through 2033.
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	37700000	usd
CY2023	ipar	Operating Lease Of Related To Rental Expenses OperatingLeaseOfRelatedToRentalExpenses	5800000	usd
CY2022	ipar	Operating Lease Of Related To Rental Expenses OperatingLeaseOfRelatedToRentalExpenses	5600000	usd
CY2021	ipar	Operating Lease Of Related To Rental Expenses OperatingLeaseOfRelatedToRentalExpenses	8200000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	5300000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4800000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	7500000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	4800000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	12200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6370000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6031000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5276000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5389000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5372000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3529000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	31967000	usd
CY2023Q4	ipar	Less Imputed Interest Based On3.0 Weightedaverage Discount Rate LessImputedInterestBasedOn3.0WeightedaverageDiscountRate	-1499000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	30468000	usd
CY2023	us-gaap	Finite Lived Intangible Assets Intent Or Ability To Renew Or Extend Arrangement FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement	The Company is party to a number of licenses and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039.
CY2023Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	288005000	usd
CY2023Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	280721000	usd
CY2023Q4	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	251718000	usd
CY2023Q4	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	233945000	usd
CY2023Q4	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	243286000	usd
CY2023Q4	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	1055918000	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	2353593000	usd
CY2023	us-gaap	Royalty Expense RoyaltyExpense	103800000	usd
CY2021	us-gaap	Royalty Expense RoyaltyExpense	68900000	usd
CY2023	ipar	Royalty Expense Net Sales Percentage RoyaltyExpenseNetSalesPercentage	0.079	pure
CY2022	ipar	Royalty Expense Net Sales Percentage RoyaltyExpenseNetSalesPercentage	0.080	pure
CY2021	ipar	Royalty Expense Net Sales Percentage RoyaltyExpenseNetSalesPercentage	0.078	pure
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	168730	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	16.31
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	47500	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	35.08
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	94130	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	15.19
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	175000	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	122100	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.47
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	441580	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	67.30
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	524900	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	57.58
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	713210	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	52.74
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	47500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	147.71
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	62000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	97.84
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	62.18
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	154220	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	52.04
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	136880	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	43.86
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	156490	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	34.46
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25890	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	76.32
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8440	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	67.65
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	40820	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	62.57
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	308970	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	86.52
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	441580	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	67.30
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	524900	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	57.58
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.29	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.26	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.25	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.038	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.040	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.004	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.020	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.024	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.016	pure
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8025000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6003000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5393000	usd
CY2023	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	1150000	usd
CY2022	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	800000	usd
CY2021	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	1300000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11578000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6760000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7800000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	308970	shares
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	186870	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	70.60
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	13700000	usd
CY2021Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.00
CY2022Q1	ipar	Percentage Of Increase In Annual Dividend PercentageOfIncreaseInAnnualDividend	1	pure
CY2022Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	2.00
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	2.50
CY2023	us-gaap	Net Income Loss NetIncomeLoss	152654000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	120938000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	87411000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31994328	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31859417	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31676796	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	145374	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	129336	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	158612	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32139702	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31988753	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31835408	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.77
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.76
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.75
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.78
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.75
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38000	shares
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1317675000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1086653000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	879516000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	152654000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	120938000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	87411000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17331000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22539000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12698000	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	10729000	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5486000	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3403000	usd
CY2023	us-gaap	Interest Expense InterestExpense	11253000	usd
CY2022	us-gaap	Interest Expense InterestExpense	3599000	usd
CY2021	us-gaap	Interest Expense InterestExpense	2825000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61817000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43182000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40992000	usd
CY2023Q4	us-gaap	Assets Assets	1369329000	usd
CY2022Q4	us-gaap	Assets Assets	1308542000	usd
CY2021Q4	us-gaap	Assets Assets	1145364000	usd
CY2023	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	6465000	usd
CY2022	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	33756000	usd
CY2021	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	141274000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	494191000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	485538000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	397127000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14545000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11159000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7936000	usd
CY2023	us-gaap	Revenues Revenues	1317700000	usd
CY2022	us-gaap	Revenues Revenues	1086700000	usd
CY2021	us-gaap	Revenues Revenues	879500000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	78962000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	50250000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	34742000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	170631000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	143969000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	116277000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	249593000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	194219000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	151019000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	12062000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6829000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4825000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	712000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	658000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	518000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	52186000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	39458000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	36164000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	64960000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	46945000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	41507000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	199000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-802000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	19000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-49000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	11000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3361000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2912000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-530000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3143000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3763000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-515000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61817000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43182000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40992000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	218000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	554000	usd
CY2023Q4	ipar	Deferred Tax Assets Inventory And Accounts Receivable DeferredTaxAssetsInventoryAndAccountsReceivable	3138000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.031	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.074	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.009	pure
CY2022Q4	ipar	Deferred Tax Assets Inventory And Accounts Receivable DeferredTaxAssetsInventoryAndAccountsReceivable	3880000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	3505000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	2871000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	613000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	716000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Intra Entity Transfer Asset Other Than Inventory DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory	10957000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Intra Entity Transfer Asset Other Than Inventory DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory	9342000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1674000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	266000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20105000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17629000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	296000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	554000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	19809000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17075000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1327000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1356000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	2238000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	2160000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1044000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1745000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-655000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-655000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5264000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5916000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	14545000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	11159000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.002	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.002	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Employee Stock Ownership Plan Dividends EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends	0.004	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Employee Stock Ownership Plan Dividends EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends	0.004	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions Employee Stock Ownership Plan Dividends EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends	0.009	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.009	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.008	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.006	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.043	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.248	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.222	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.271	pure
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-40188000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-56056000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-38432000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	159613000000	usd
CY2021Q4	ipar	Cash Held In Escrow Included In Other Assets CashHeldInEscrowIncludedInOtherAssets	8774000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168387000000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	47000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001753926-24-000405-index-headers.html	Edgar Link	pending
0001753926-24-000405-index.html	Edgar Link	pending
0001753926-24-000405.txt	Edgar Link	pending
0001753926-24-000405-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g084061_10k.htm	Edgar Link	pending
g084061_ex21.htm	Edgar Link	pending
g084061_ex23.htm	Edgar Link	pending
g084061_ex31-1.htm	Edgar Link	pending
g084061_ex31-2.htm	Edgar Link	pending
g084061_ex32-1.htm	Edgar Link	pending
g084061_ex32-2.htm	Edgar Link	pending
img001_v1.jpg	Edgar Link	pending
ipar-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
ipar-20231231_cal.xml	Edgar Link	unprocessable
ipar-20231231_def.xml	Edgar Link	unprocessable
ipar-20231231_lab.xml	Edgar Link	unprocessable
ipar-20231231_pre.xml	Edgar Link	unprocessable
g084061_10k_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IPAR
INTERPARFUMS INC Stock $ipar

2024 Q1 Form 10-K Financial Statement

#000175392624000405 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPAR INTERPARFUMS INC Stock $ipar

2024 Q1 Form 10-K Financial Statement

#000175392624000405 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPAR
INTERPARFUMS INC Stock $ipar